Starling Oncology, Inc.
DFPH- Exchange
- OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $261.1K in total
- 3
- Insider sellsLast 90 days, $2.10M in total
- 2
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DFPH, Q2 2026
No superinvestor reported holding DFPH at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Starling Oncology, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:11 PM ET | Aug 21 | 3 days | Hively BradDirector | SSale | −298.9K | $6.51 | −$1.95M | −42.0%412.0K after | 10b5-1 |
| Aug 17, 2026 (view filing)10:13 AM ET | Aug 14 | 3 days | Chernett Jorey10% Owner | PPurchase | +12.0K | $6.54 | +$78.5K | +0.1%10.7M after | |
| Aug 17, 2026 (view filing)10:13 AM ET | Aug 13 | 4 days | Chernett Jorey10% Owner | SSale | −10.0K | $0.0624 | −$624 | –0 after | Derivative |
| Jul 22, 2026 (view filing)9:55 AM ET | Jul 21 | 1 day | Chernett Jorey10% Owner | PPurchase | +18.0K | $5.27 | +$94.9K | +0.2%10.6M after | |
| Jul 16, 2026 (view filing)8:05 PM ET | Jul 14 | 2 days | Podnos YaleChief Medical Officer | SSale | −23.5K | $6.41 | −$150.3K | −8.3%259.5K after | 2 lots10b5-1 |
| Jul 13, 2026 (view filing)11:34 AM ET | Jul 10 | 3 days | Chernett Jorey10% Owner | PPurchase | +15.0K | $5.85 | +$87.8K | +0.1%10.6M after | |
| Jun 24, 2026 (view filing) | Jun 23 | 1 day | Chernett Jorey10% Owner | PPurchase | +18.0K | $5.02 | +$90.4K | +0.2%10.6M after | |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Podnos YaleChief Medical Officer | SSale | −23.5K | $5.38 | −$126.2K | −8.3%259.5K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Chernett Jorey10% Owner | PPurchase | +12.0K | $4.75 | +$57.0K | +0.1%10.6M after | |
| May 21, 2026 (view filing) | May 19-20 | 2 days | Chernett Jorey10% Owner | PPurchase | +38.5K | $4.07 | +$156.6K | +0.4%10.6M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Starling Oncology, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding DFPH in 13F filings for Q2 2026.